Neumora Therapeutics, Inc. - Common Stock (NMRA)

Neumora Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for neurodegenerative diseases and psychiatric disorders

The company utilizes a precision medicine approach to target underlying biological mechanisms and aims to create treatments that significantly improve the lives of patients suffering from these conditions. By leveraging advanced drug discovery and development techniques, Neumora is dedicated to addressing unmet medical needs in the field of neuroscience, with a mission to enhance therapeutic outcomes and promote better mental health.